Determination of pancreatic left/right asymmetry

pathway activity — cross-omics
GO:0035469Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Determination of pancreatic left/right asymmetry pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SPATA9, RNU6-737P, and MIR362, each associated with the pathway in up to 2 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Determination of pancreatic left/right asymmetry activity versus SPATA9 in LSCC (Pearson r = -0.31).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCSPATA9 →-0.172-0.651<.001.00232
LSCCRNU6-737P →+0.275+1.165.001.00232
LSCCMIR362 →+0.420+0.751.002<.00132
UCECDACT1 →-0.785-1.028<.001<.00132
LUADTRIM49C →-0.052-0.491.001.00432
LUADTESC →+1.514+0.593.004.00832
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0035469 vs SPATA9 — LSCC

Per-sample scatter of Determination of pancreatic left/right asymmetry activity vs SPATA9 in LSCC.

Explore this scatter interactively →

Exploration